Point mutation in the mouse P2X7 receptor affects intercellular calcium waves in astrocytes by Suadicani, Sylvia O et al.
Point mutation in the mouse P2X7
receptor affects intercellular calcium
waves in astrocytes
Sylvia O Suadicani*
,{, Rodolfo Iglesias*, David C Spray* and Eliana Scemes*
1
*Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A.
{Department of Urology, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A.
Cite this article as: Suadicani SO, Iglesias R, Spray DC and Scemes E (2009) Point mutation in the mouse P2X7 receptor affects intercellular calcium
waves in astrocytes. ASN NEURO 1(1):art:e00005.doi:10.1042/AN20090001
ABSTRACT
Purinergic P2 receptors and gap junctions are two groups
of proteins involved in the transmission of ICWs (inter-
cellular calcium waves) between astrocytes. The extent to
which ICWs spread among these glial cells depends on the
amount of ATP released, which can occur through
membrane channels, as well as other pathways. Our
previous studies have shown that the pore-forming
P2X7R (P2X7 receptor) contributes to the amplification of
ICW spread by providing sites of ATP release through Panx1
(Pannexin1) channels. To gain insight into the signal
transduction events mediating this response we compared
the properties of the P2X7R–Panx1 complex in astrocytes
from a mouse strain (C57Bl/6) containing a naturally
occurring point mutation (P451L) in the C-terminus of the
P2X7R to that of non-mutated receptors (Balb/C mice).
Electrophysiological, biochemical, pharmacological and
fluorescence imaging techniques revealed that the P451L
mutation located in the SH3 domain (a Src tyrosine kinase-
binding site) of the C-terminus of the P2X7R attenuates
Panx1 currents, ATP release and the distance of ICW spread
between astrocytes. Similar results were obtained when
using the Src tyrosine inhibitor (PP2) and a membrane-
permeant peptide spanning the P451L mutation of the
P2X7R of the C57Bl6 astrocytes. These results support the
participation of a tyrosine kinase of the Src family in the
initial steps mediating the opening of Panx1 channels
following P2X7R stimulation and in the transmission of
calcium signals among astrocytes.
Key words: ATP release, gap junction, glia, hemichannel,
pannexin, purinergic receptor.
INTRODUCTION
Astrocytes in vitro and in vivo express several purinergic P2
receptors of the ionotropic P2X and metabotropic P2Y types
(reviewed in Burnstock, 2008). The ionotropic P2X7R (P2X7
receptor) is remarkable in that brief stimulation opens the
cation channels, but prolonged stimulation leads to the
opening of a pore through which large molecules (up to
approx. 800 Da) can pass into or out of the cells (Surprenant
et al., 1996; North, 2002). Mutagenic studies have indicated
that deletion of the intracellular CT (C-terminal) domain of
the P2X7R abrogates membrane permeabilization induced by
prolonged agonist stimulation (Surprenant et al., 1996). More
recently, a genetic polymorphism was described in mice in
which the proline residue at position 451 of the P2X7RC Ti s
replaced by a leucine residue; this single-amino-acid
mutation rendered the P2X7R still capable of performing as
a cation channel, but largely attenuated pore formation
(Adriouch et al., 2002; Le Stunff et al., 2004).
Examination of the region flanking this mutation revealed
that it may represent a tyrosine-kinase-binding site, which
could suggest a mechanism whereby activation of the pore
component of the complex could be selectively modulated.
Such modulation could be of considerable importance in
long-range signalling in astrocytes where the P2X7R complex
provides regenerative signal relay for the transmission of
ICWs (intercellular calcium waves) (Anderson and Nedergaard,
2003; Duan et al., 2003; Anderson et al., 2004; Suadicani et
al., 2006).
Recent studies have revealed that the gap junction-like
protein Panx1 (Pannexin1), a vertebrate homologue of
invertebrate gap junction proteins, is part of the pore
forming unit of the P2X7R (Pelegrin and Surprenant, 2006;
Locovei et al., 2007; Iglesias et al., 2008). As such, non-
ASN NEURO AN090001GOS.3d 9/4/09 15:13:31
1To whom correspondence should be addressed (email scemes@aecom.yu.edu).
Abbreviations: CBX, carbenoxolone; CCD, charge-coupled device; CT, C-terminal; DMEM, Dulbecco’s modified Eagle’s medium; DPBS, Dulbecco’s PBS; FBS, fetal bovine
serum; HRP, horseradish peroxidase; ICW, intercellular calcium wave; LDPBS, low-divalent PBS; LY, Lucifer Yellow; MFQ, mefloquine; Panx1, Pannexin1; P2X7R, P2X7
receptor; siRNA, small interfering RNA.
E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://
creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is
properly cited.
RESEARCH ARTICLE
ASN NEURO 1(1):art:e00005.doi:10.1042/AN20090001
asnneuro.org / Volume 1 (1) / art:e00005 55junctional channels formed by Panx1 provide sites of ATP
release from several cell types including erythrocytes, taste
bud cells and astrocytes (Locovei et al. 2006a; Huang et al.,
2007a; Scemes et al., 2007).
In the present study we used astrocytes obtained from two
mouse strains, the C57Bl/6 strain which contains a P451L
mutation in the P2X7R CT, and the Balb/C strain which
contains non-mutated receptors, to investigate the extent to
which activation of Panx1 through the P2X7R depends on the
proper amino acid sequence of the P2X7R. Our findings
indicate that the sequence spanning the SH3 domain of the
P2X7R determines the magnitude of the P2X7R-mediated
Panx1 inward currents, ATP release and transmission of
calcium waves in astrocytes.
MATERIALS AND METHODS
Astrocyte cultures
Primary cultures of cortical astrocytes derived from neonatal
Balb/C and C57Bl/6J mice were prepared as previously
described (Scemes and Spray, 1998). Briefly, cortices were
separated from whole brains after removal of meninges and
trypsinized (0.1% trypsin at 37˚C). Cells were collected by
centrifugation [355 g for 5 min at room temperature (23˚C)],
pellets were suspended in DMEM (Dulbecco’s modified Eagle’s
medium; CellGro) supplemented with 10% (v/v) FBS (fetal
bovine serum; Gibco) and antibiotics (50 units/ml penicillin
and 50 mg/ml streptomycin; CellGro), and cells were seeded in
60 mm culture dishes. Astrocyte cultures were maintained for
2–3 weeks in culture (100% humidity; 95% air/5% CO2 at
37˚C) at which time approx. 95–98% of the cells in culture
were immunopositive for GFAP (glial fibrillary acidic protein).
A l la n i m a lh a n d l i n ga n de x p erimental protocols were
approved by the Animal Care and Use Committee of the
Albert Einstein College of Medicine.
Electrophysiology
Astrocytes were plated at low density on coverslips 24–48 h
prior to recordings, as previously described (Iglesias et al.,
2008; R. Iglesias, G. Dahl, F. Qiu, D.C. Spray and E. Scemes,
unpublished data). Briefly, the whole-cell patch–clamp
configuration was performed at room temperature on solitary
astrocytes bathed in external solution containing 147 mM
NaCl, 10 mM Hepes, 13 mM glucose, 2 mM CaCl2,1m M
MgCl2 and 5 mM KCl (pH 7.4). The pipette solution contained
130 mM CsCl, 10 mM EGTA, 10 mM Hepes and 0.5 mM CaCl2
(pH 7.2). Activation of Panx1 channels by voltage was
performed using a ramp protocol with voltages from the
holding potential of 260 mV to +100 mV. To analyse the
participation of Panx1 channels in agonist-induced P2X7R
activation, the P2X7R agonist BzATP (50 mM; Sigma–Aldrich)
was superfused for 5–10 s. After the first response to the
agonist, test compounds were superfused for 5 min prior to
the second addition of the P2X7R agonist and, 5 min after
rinsing, agonist was re-applied to test reversibility.
Compounds included the gap junction and Panx1 channel
blockers MFQ (mefloquine; BioBlocks; used at 100 nM) and
CBX (carbenoxolone; Sigma; used at 50 mM), and the Src
inhibitor PP2 (Tocris; used at 100 mM). Electrophysiological
recordings were obtained using an Axopatch 200B amplifier
and pClamp9 software for data acquisition and analysis.
Panx1 siRNA (small interfering RNA)
In some experiments, astrocytes were treated with 50 nM
siRNA corresponding to the mouse Panx1 sequence
(GGUGCUGAACAUUAAA) using 6 ml of siRNA/1.5 ml of
Oligofectamine
TM reagent (Invitrogen), as previously
described (Locovei et al., 2007; Scemes et al., 2007; Iglesias
et al., 2008). After overnight exposure, transfection reagents
were removed and cells were incubated for 30 h in DMEM/
FBS before use.
TAT-P2X7 peptides
Membrane permeant TAT peptides (SLHDSPPTPGQGGGYGRK
KRRQRRR; 78–90% purity) corresponding to the SH3 domain
of the Balb/C mouse P2X7R CT were synthesized by
GeneScript. For the assays, cells were treated for 15 min
with 10 mM of the TAT-P2X7 peptide at 37˚C, as previously
described (Iglesias et al., 2008).
LY (Lucifer Yellow) microinjections
To evaluate the degree of dye-coupling between astrocytes in
confluent cultures derived from C57Bl/6 and Balb/C mice, we
used the microinjection assay. Astrocytes were impaled with a
microelectrode (25 MV when filled with 3 M KCl) filled with
the gap-junction-permeant fluorophore LY [5% (w/v) in 150
mM LiCl; Sigma–Aldrich] and the dye was injected by
iontophoresis (continuous current of 0.1 mA) for 5 min using
an electrometer (Model 3100; A-M Systems). After removal of
the microelectrode from the injected cell, images were
immediately acquired using a CoolSNAP-HQ2 CCD (charge-
coupled device) camera (Photometrics) attached to a Nikon
inverted microscope equipped with 106dry objective (NA
0.3) and FITC filter sets. The number of cell tiers surrounding
the injected cell containing LY were counted and the results
expressed as the mean¡S.E.M.; at least 10 injections were
performed in 3–4 different astrocyte cultures.
ATP release
The amount of ATP released in the bathing solution from
astrocytes pre-stimulated with BzATP was measured using the
luciferin/luciferase assay (Molecular Probes, Invitrogen), as
previously described (Striedinger et al., 2007; Striedinger and
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mm dishes were washed twice in PBS and then exposed for 3
min at room temperature to PBS containing 300 mM BzATP.
After complete removal and washout of the agonist, cells
were bathed in PBS for 2 min before collection of samples of
BzATP-induced ATP release. Intracellular ATP levels were
measured from supernatants following whole-cell lysis in
Tris-buffered solution (10 mM Tris and 150 mM NaCl, pH 7.4)
containing 1% Triton X-100. Extracellular ATP (released into
the bathing solution from stimulated and non-stimulated
astrocytes) was measured from aliquots of bathing solution.
For each measurement, 50 ml of a buffered solution
containing luciferin (50 mM) and luciferase (1.25 mg/ml)
was placed in triplicate in a 96-well plate luminometer
(Veritas) for background luminescence subtraction. Reactions
were started by adding 5 ml of the experimental samples and
luminescence values acquired using a 1 s integration time.
The amount of ATP in the samples was calculated from
standard curves (using ATP from 50 nM to 5000 nM) and
normalized for the total amount of protein, using the BCA
(bicinchoninic acid) assay (Pierce).
ICWs
Confluent astrocyte cultures plated on glass-bottomed
MatTek dishes (MatTek) were loaded for 30 min at 37˚C with
5 mM Fluo-3-AM (Molecular Probes, Invitrogen) and then
bathed in DPBS (Dulbecco’s PBS, pH 7.4; Cellgro). ICWs were
induced by focal mechanical stimulation of single astrocytes
and the radius of calcium wave spread from the point of
stimulation was measured before and after exposure to
LDPBS (low-divalent PBS; containing nominally zero Ca
2+ and
43 mM MgCl2, prepared by dissolving 1 mM MgCl2 and 1 mM
EDTA in the Ca
2+- and Mg
+2-free DPBS), as previously
described (Suadicani et al., 2006). Images were acquired using
a Nikon TE2000 inverted microscope equipped with a CCD
camera (Orca-ER; Hamamatsu Photonics) and a 106Plan
Fluor objective (NA 0.3). Changes in Fluo-3 fluorescence
intensity emitted at 488 nm excitation (Lambda DG-4; Sutter
Instruments) were acquired at 1 Hz using Metafluor software
(Molecular Devices).
Western blot analysis
Samples of whole-cell lysates were electrophoresed in SDS/
PAGE (4–20%) mini-gels (Bio-Rad) and then transferred to
nitrocellulose membranes (Whatman). Immunoblots using
primary antibodies were performed after 1 h incubation of
membranes with blocking solution [2% (w/v) dry non-fat milk
in 16PBS containing 0.4% Tween 20; Sigma–Aldrich]. After
several washes with 16PBS/Tween 20, membranes were
incubated with HRP (horseradish peroxidase)-conjugated
secondary antibodies (goat anti-rabbit-HRP, 1:2000; goat
anti-mouse-HRP, 1:2000; rabbit anti-chicken-HRP, 1:500; all
from Santa Cruz Biotechnology). Detection of bands was
performed on X-ray films (Kodak) following incubation with
ECL (enhanced chemiluminescence) reagents (Amersham
Pharmacia Biotechnology). The rabbit anti-P2X7R antibody
(1:500; Alomone), chicken anti-Panx1 antibody (1:2000; a
gift from Dr Gerhard Dahl, Department of Physiology and
Biophysics, University of Miami, Miami, FL, U.S.A.), and the
mouse anti-GAPDH antibody (glyceraldehyde-3-phosphate
dehydrogenase, 1:10000; Fitzgerald International) were used
in the present study.
RESULTS
P2X7R-mediated Panx1 currents are distinct in
astrocytes of two mouse strains
To evaluate whether P2X7R-mediated activation of Panx1
channels in astrocytes involved the domain surrounding the
P451L point mutation on the P2X7R, we performed
electrophysiological studies on cortical astrocytes derived
from C57Bl/6 and Balb/C mice. As shown in Figure 1, 50 mM
BzATP induced larger currents in Balb/C astrocytes
(461.6¡29.3 pA, n57 cells) than in C57Bl/6 astrocytes
(352.9¡19.72 pA, n59 cells; P,0.05, measured using an
unpaired Student’s t test) (Figure 1A). Bath application of gap
junction and Panx1 blockers MFQ (100 nM) or CBX (50 mM),
greatly blocked Panx1 currents in both cell types. The
remaining MFQ- and CBX-insensitive currents, most likely
due to cation flux through the P2X7R channel, were not
significantly different in astrocytes of the two mouse strains
[Balb/C(MFQ), 120.3¡19.6 pA, n54 cells; C57Bl/6(MFQ),
108.8¡17.7 pA, n54 cells; Balb/C(CBX), 89.0¡11.4 pA, n56
cells; C57Bl/6(CBX), 89.9¡28.3 pA, n56c e l l s ;P.0.05,
measured using an unpaired Student’s t test; Figure 1A].
Evidence that the larger currents evoked by BzATP in Balb/C
as compared with C57Bl/6 astrocytes were unrelated to
altered activity of Panx1 channels in these strains was
obtained using electrophysiological recordings. As shown in
Figure 1(B), similar amplitudes of voltage-activated Panx1
currents were recorded in astrocytes from both mouse strains
in response to voltage ramps (Balb/C, 472.0¡65.4 pA, n58
cells; C57Bl/6, 567.2¡59.8 pA, n512 cells; P.0.05, measured
using an unpaired Student’s t test). The gap junction and
Panx1 blocker CBX (50 mM) greatly reduced Balb/C and
C57Bl/6 voltage-activated outward currents to similar levels
[Balb/C(CBX), 383.7¡26.6 pA, n54 cells; C57Bl/6(CBX),
444.8¡47.9 pA, n54 cells; P.0.05, measured using an
unpaired Student’s t test]. Moreover, since no significant
changes in Panx1 and P2X7R protein expression levels were
detected by Western blot analysis (Figure 1C), it is likely that
current amplitude differences recorded between the two
types of astrocytes in response to BzATP (see Figure 1A) are
related to the single point mutation of the P2X7R, which is
probably an important site for the signal transduction events
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57leading to Panx1 channel opening following receptor
activation.
Functional implications of the P2X7R P451L
mutation to astrocyte calcium signalling
Our previous studies indicated that the P2X7R and Panx1
contribute to the transmission of calcium signals among
astrocytes by providing sites of ATP release (Suadicani et al.,
2006; Scemes et al., 2007). In order to evaluate the functional
implications of the P451L point mutation of the P2X7RC Tf o r
astrocyte intercellular communication, we measured the
amount of ATP released and the distance of ICW transmission
between astrocytes derived from C57Bl/6 and Balb/C mice.
Pre-treatment of astrocytes with 300 mM BzATP for 3 min
induced subsequent ATP release (Figure 2A). The amount of
ATP present in the bathing solution of stimulated cells was 3-
fold higher in Balb/C than in C57Bl/6 astrocytes (Balb/C,
1030.0¡35.5 nM; C57Bl/6, 348.0¡24.6 nM; n512 measure-
ments; P,0.001, measured using an unpaired Student’s t
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Figure 1 The proline-rich region of the P2X7R CT mediates activation of Panx1 channels
(A) Top panel: examples of current traces obtained from Balb/C and C57Bl/6 astrocytes induced by a 5 s application (indicated by
arrows) of BzATP (50 mM) are greatly reduced by 60 s pre-incubation (lines) with 100 nM MFQ and 50 mM CBX; after a 5 min
washout of blockers, agonist-induced currents were of similar amplitudes as those recorded after the first application. Bottom panel:
histograms show the mean values¡S.E.M. obtained from 4–6 cells. Note the significantly smaller currents recorded from C57Bl/6
astrocytes compared with those recorded from Balb/C cells following agonist application. Astrocytes were plated on cover slips at a
low density and recordings were performed on solitary astrocytes while holding the membrane potential at 260 mV. (B) Top panel:
an example of current traces obtained from Balb/C astrocytes recorded during a voltage ramp performed in the absence (control) and
presence of CBX (50 mM), and after CBX washout. Bottom panel: histograms showing the mean values¡S.E.M. of current amplitudes
induced by voltage ramps (260 to +100 mV) at a 260 mV holding potential recorded from Balb/C and C57Bl/6 astrocytes (n54–12
cells) in the absence (CTRL) and presence of 50 mM CBX. Note that current amplitudes at +100 mV were not significantly different in
astrocytes derived from the two mouse strains and that CBX significantly reduced voltage-activated outward currents in both cell
types. (C) Left-hand panel: histograms showing the mean values¡S.E.M. (n55 independent experiments) of P2X7R and Panx1
expression levels in the two mouse strains, indicating that in Balb/C and C57Bl/6 astrocytes these two proteins are equally expressed.
Right-hand panel: representative blot showing expression of Panx1 and P2X7R in Balb/C and C57Bl/6 astrocytes. **P,0.0001
(compared with the control) was obtained using one-way ANOVA, followed by Newman–Keuls multiple comparison test.
$$P,0.05
(measured using a Student’s t test) was obtained when comparing amplitudes of BzATP-induced inward currents in Balb/C and
C57Bl/6 astrocytes. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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release was obtained by the finding that MFQ blocked ATP
release from astrocytes of both mouse strains (Balb/C, from
1030.0¡35.5 nM to 466.7¡20.3 nM, n59–12 measure-
ments; C57Bl/6, from 348.0¡24.6 nM to 217.9¡14.4 nM,
n59–12 measurements; Figure 2A). Because Balb/C and
C57Bl/6 cultured astrocytes have similar intracellular ATP
levels (Balb/C, 14465.0¡1986.0 nM; C57Bl/6, 9967.0¡
1289.0 nM; n512, P.0.05; inset in Figure 2A), and express
similar levels of P2X7R and Panx1 proteins (Figure 1C), it is
likely that the P451L mutation in the P2X7R of C57Bl/6
interferes with P2X7R–Panx1-mediated ATP release.
ICW transmission in astrocytes has been shown to be
mediated by ATP-sensitive P2Rs and by gap junctions
(reviewed in Scemes and Giaume, 2006). For efficient calcium
signal transmission between astrocytes, the levels of ATP
released play important roles affecting both modes of
transmission (extracellular and intercellular). Higher levels
of ATP will diffuse longer distances and thus activate cells
further away and also will generate higher levels of calcium-
mobilizing second messengers that are permeable to gap
junction intercellular channels. Thus it would be expected
that ICWs would travel shorter distances if the amount of ATP
released was reduced. Figure 2(B) shows that, indeed, the
radius of ICW spread between C57Bl/6 astrocytes bathed in
LDPBS is smaller than that between Balb/C cells (C57Bl/6,
299.0¡6.3 mm; Balb/C, 352.5¡16.0 mm; P,0.05, measured
using a Student’s t test; n562–347 radius measurements,
from 20–87 fields; Figure 2B). To evaluate for possible
differences in gap-junctional coupling among astrocytes
from the two mouse strains that might have contributed to
the extent of ICW spread, we used the LY microinjection
approach. Results from these experiments indicated that the
degree of dye-coupling in confluent cultures of Balb/C
(4.7¡0.2 cell tiers, n548 measurements from 12 injections)
and C57Bl/6 (5.0¡0.2 cell fields, n560 measurements from
15 injections) astrocytes was not statistically different
(P50.30, measured using an unpaired Student’s t test).
Taken together these results suggest that decreased P2X7R–
Panx1-mediated ATP release from C57Bl/6 astrocytes reduces
the distance of spread of ICW compared with that of Balb/C
cells.
To determine whether Panx1 participates in the amplifica-
tion of ICWs, the radius of mechanically induced ICWs was
measured in the presence of the Panx1 channel inhibitor
MFQ. As shown in Figure 2(B), blockade of Panx1 with 100
nM MFQ prevented amplification of ICWs in both types of
astrocytes (Balb/C, from 352.5¡16.0 mm to 217.5¡9.7 mm,
P,0.0001, measured using an unpaired Student’s t test,
n524–62 radii from 6–16 fields; C57Bl6, from 299.0¡6.3 mm
to 208.3¡11.5 mm, P50.0002, measured using an unpaired
Student’s t test, n524–347 radii from 6–87 fields). This
blockade of ICW amplification was similar to that recorded
when Panx1 expression was knocked-down using siRNA
(Balb/C, from 352.5¡16.0 mm to 191.4¡7.6 mm, n524–80
radii from 6–20 fields; C57Bl/6, from 286.1¡16.1 mmt o
207.8¡8.2 mm, n552–80 radii from 13–20 fields; see also
Figure 4 in Scemes et al., 2007). These later results therefore
support the hypothesis that Panx1 in astrocytes may, under
defined conditions, function as a conduit for the release of
ATP, as has been shown for other cell types (Huang et al.,
2007a; Locovei et al., 2006a).
The SH3 domain surrounding the P451L
mutation of the P2X7R contributes to Panx1
activation and amplification of ICWs
We have recently shown in a macrophage cell line that
interaction of a Src tyrosine kinase to the SH3 domain of the
P2X7R leads to the activation of Panx1 (Iglesias et al., 2008). To
evaluate whether a transduction mechanism similar to that
reported in J774 macrophages was also present in astrocytes,
we used the Src inhibitor PP2 in electrophysiological studies.
As shown in Figure 3(A) our electrophysiological results
indicate that PP2 (100 mM) significantly attenuates the
BzATP-induced inward current in Balb/C astrocytes by 57%
(from 553.0¡43.3 pA to 313.0¡55.3 pA, n54 cells; P,0.05,
measured using an unpaired Student’s t test). In contrast with
Balb/C astrocytes, PP2 (100 mM) did not significantly decrease
inward currents activated by brief application of 50 mM
BzATP in C57Bl/6 astrocytes (from 360.4¡37.5 pA to
268.1¡33.7 pA, n54 cells; P.0.05, measured using an
unpaired Student’s t test; Figure 3A).
Thus these results suggest that the opening of Panx1
channels in Balb/C astrocytes following P2X7R stimulation
most likely involves a tyrosine kinase of the Src family. The
poor efficacy of PP2 to prevent Panx1 activation in C57Bl/6
astrocytes is probably related to the single point mutation
(P451L) in the P2X7R in these cells, which may interfere with
interaction with the P2X7R and is necessary for proper Src
signalling and Panx1 recruitment into the response.
In agreement with electrophysiological recordings, the
amplification of ICWs (from 246.2¡5.9 mm to 352.5¡16.0
mm, n562–118 radii; Figure 3B) seen in Balb/C astrocytes was
totally prevented by PP2 (255.2¡15.6 mm, n521 radii;
Figure 3B), whereas this Src inhibitor did not prevent
amplification of ICW spread between C57Bl/6 astrocytes
[ICW(PBS)5189.4¡6.0 mm, n595 radii; ICW(LDPBS)5
299.0¡6.3 mm, n5347 radii; ICW(LDPBS+PP2)5263.3¡10.1
mm, n524 radii; Figure 3B].
Further support for the participation of the P2X7R SH3
domain in the transduction signalling events leading to the
agonist-induced Panx1 channel opening was obtained by
treating astrocytes with a membrane-permeant peptide (TAT-
P2X7) spanning the P451L mutation of the P2X7R SH3
domain. As shown in Figure 3(B), the TAT-P2X7 peptide, which
we have previously shown to block BzATP-induced Panx1
currents (Iglesias et al., 2008), prevented the amplification of
ICWs among astrocytes derived from Balb/C [ICW(LDPBS)5
352.5¡16.0 mm, n562 radii; ICW(LDPBS+peptide)5273.3¡21.4
mm, n512 radii; P,0.05, measured using an unpaired
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Figure 2 Astrocytes from Balb/C and C57Bl/6 mice release different amounts of ATP and display distinct ranges of ICW transmission
(A) Histograms showing the mean values¡S.E.M. of intracellular ATP content (inset) and the amount of ATP released from Balb/C
(solid bars) and C57Bl/6 (open bars) astrocytes following BzATP (300 mM) addition in the absence and presence of MFQ (100 nM).
Note the similar intracellular ATP levels in both mouse strain astrocytes (inset), and the significantly lower levels of basal and BzATP-
induced ATP release in C57Bl/6 compared with Balb/C astrocytes. (B) Histograms showing mean values¡S.E.M. of the radius of
mechanically induced ICW spread in Balb/C (solid bars) and C57Bl/6 (open bars) astrocyte cultures when bathed in PBS and in LDPBS,
in the absence and presence of MFQ (100 nM). Note the shorter distance of ICW spread in C57Bl/6 compared with Balb/C astrocyte
cultures and the inhibition of ICW amplification in both types of astrocytes by MFQ. **P,0.0001 (compared with control) was
obtained using one-way ANOVA, followed by Newman–Keuls multiple comparison test.
Figure 3 A Src tyrosine kinase mediates Panx1 activation through P2X7R
(A) Histograms showing the mean values¡S.E.M. of current amplitudes induced by BzATP (50 mM) while holding the membrane
potential at 260 mV recorded from Balb/C (solid bars) and C57Bl/6 (open bars) astrocytes in the absence and presence of PP2 (10
mM) (n54 cells). Note that PP2 significantly reduced current amplitudes in Balb/C, but not in C57Bl/6, astrocytes. (B) Histograms of
the mean values¡S.E.M. of the ICW radius obtained from Balb/C (solid bars) and C57Bl/6 (open bars) astrocytes when bathed in PBS
and LDPBS untreated and treated with MFQ, PP2 and TAT-P2X7 peptide. Note that the exposure to PP2 and the TAT-P2X7 peptide
prevented the amplification of ICW seen in LDPBS only in Balb/C astrocytes. **P,0.0001 (compared with control) was obtained using
one-way ANOVA, followed by Newman–Keuls multiple comparison test.
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299.0¡6.3 mm, n5347 radii; ICW(LDPBS+peptide)5301.0¡11.3
mm, n520 radii] mice. Our results therefore support the
hypothesis that the SH3 domain of the P2X7R is an important
site that leads to Panx1 channel opening.
DISCUSSION
Release of ‘gliotransmitters’ from astrocytes allows modu-
lation of neuronal activity, controls blood flow in the brain
and contributes to long-range calcium signalling. Diverse
mechanisms have been described to be involved in ‘glio-
transmitter’ release from astrocytes, including diffusion
through regulated secretion and pore-forming membrane
channels (Duan and Neary, 2006; Kimelberg et al., 2006;
Montana et al., 2006; Oliet and Mothet, 2006; Spray et al.,
2006). Among these channels, the pore-forming P2X7R plays
a dual role in cell signalling; as a cation channel it contributes
to the total calcium influx, promoting the calcium-dependent
release of glutamate and GABA from pre-synaptic nerve
terminals (Deuchars et al., 2001; Lundy et al., 2002; Sperlagh
et al., 2002; Miras-Portugal et al., 2003; Papp et al., 2004),
and as a pore-forming channel it plays an important role in
glia calcium signalling by providing sites of ATP and
glutamate release (Duan et al., 2003; Anderson et al., 2004;
Suadicani et al., 2006).
The first demonstration that the P2X7R was associated with
a large, non-selective conductance (called the ‘P2Z’ pore)
activated by prolonged or repetitive ATP stimulation was
provided by Surprenant et al. (1996). At that time, two
hypotheses were proposed to explain the permeabilizing
nature of the P2X7R: that the changes in permeability were
related to conformational alteration of the P2X7R itself
provided by its CT, and that the CT interacted with another
protein with permeabilization capabilities (Surprenant et al.,
1996; Coutinho-Silva and Persechini, 1997; Persechini et al.,
1998; Virginio et al., 1999; Smart et al., 2002; Boldt et al.,
2003; Faria et al., 2005; Schachter et al., 2008). The second
hypothesis gained support, about a decade later, when Panx1
was identified as being the P2X7R pore unit that allows the
diffusion of large molecules across the plasma membrane
following receptor stimulation (Pelegrin and Surprenant,
2006; Locovei et al., 2007; Iglesias et al., 2008).
Panx1 forms large conductance (400–500 pS) voltage- and
mechano-sensitive channels that can also be activated
following P2 receptor stimulation (Bao et al., 2004; Locovei
et al., 2006b). Panx1 transcripts are found in astrocytes
in vitro and in vivo (Huang et al., 2007b; Cahoy et al., 2008),
and the channels formed by this protein possess properties
that have been attributed to connexin hemichannels
(Figure 1; R. Iglesias, G. Dahl, F. Qiu, D.C. Spray and E.
Scemes, unpublished data).
Regarding the mechanisms by which Panx1 is recruited by
the P2X7R activation, we recently reported that, in a
macrophage cell line, an Src tyrosine kinase, which was
found associated to the P2X7R complex, is an important
signalling molecule mediating the initial steps leading to
activation of Panx1 through the P2X7R (Iglesias et al., 2008).
Support for the participation of Src was obtained by showing
that both a membrane-permeant peptide spanning the P2X7R
SH3 domain and the Src tyrosine kinase inhibitor, PP2, greatly
attenuated P2X7R-induced Panx1 currents and membrane
permeabilization in this macrophage-like cell (Iglesias et al.,
2008).
In the present study we have obtained further evidence
pointing to the importance of the SH3 domain located within
the P2X7R CT for optimal recruitment of Panx1 into the
response following receptor activation. For this, we compared
astrocytes derived from two mouse strains in which the
P2X7R amino acid sequence differs. In the C57Bl/6 mouse
strain, a single amino acid mutation has been shown to
impair pore formation (Adriouch et al., 2002; Le Stunff et al.,
2004), most likely because the P451L mutation renders a
region of the CT of the P2X7R less effective as an SH3-binding
domain than in the non-mutated Balb/C strain.
In agreement with these previous studies, our results
revealed that Balb/C astrocytes display larger Panx1 currents
and release significantly more ATP following P2X7R
activation, and display extended transmission of ICWs, than
C57Bl/6 astrocytes. Furthermore, our results showing that
both a membrane-permeant peptide spanning the P451L
point mutation (TAT-P2X7 peptide) and the Src tyrosine
kinase inhibitor, PP2, prevented the amplification of ICWs
between Balb/C astrocytes, and that PP2 reduced Panx1
currents following P2X7R activation, greatly support the
hypothesis that the proline-rich region of the receptor is an
important domain for an Src tyrosine kinase-mediated signal
transduction event that leads to activation of Panx1
channels.
Our results showing that a spontaneous point mutation
(P451L) in the mouse P2X7R has a great impact on receptor
function is also in accordance with previous studies
performed on rodent and human P2X7R mutants, indicating
t h a tp o l y m o r p h i s m si nt h eC TS H 3d o m a i nl e a dt o
dysfunctional receptors (Adriouch et al., 2002; Le Stunff et
al., 2004). Interestingly, from the stand-point of brain
function, a single nucleotide polymorphism, resulting in the
missense mutation Q460R (12q23–24 region) has been linked
to mood disorders such as bipolar and major depressive
disorders (Barden et al., 2006; Lucae et al., 2006; McQuillin et
al., 2008). It is not yet clear how altered function of the
P2X7R would mediate these CNS (central nervous system)
disorders. One possible scenario includes the existence of an
inflammatory signalling pathway involving the P2X7R–Panx1
complex in astrocytes, as has been described for immune
cells. For instance, in macrophages, activation of Panx1 has
been shown to play crucial roles in inflammation and to
interact with the inflammasome leading to the processing
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61and release of cytokines [IL (interleukin)-1b and IL-18]
(Pelegrin and Surprenant, 2006; Kanneganti et al., 2007). The
existence of such an inflammatory P2X7R–Panx1 complex in
astrocytes may endow these cells with a mechanism to alter
production of cytokines, chemokines, and growth and trophic
factors, consistent with findings showing changes in
circulating inflammatory mediators in blood samples of
patients with mood disorders (Song et al., 1994; Maes et al.,
1995; Barden et al., 2006). Thus, our present results showing
that the P2X7R P451L mutation alters Panx1-mediated ATP
release and long-range calcium signalling among astrocytes
suggest that interference with such signalling may have a
wide impact on brain function.
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